GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Scaled Net Operating Assets

NextCell Pharma AB (OSTO:NXTCL) Scaled Net Operating Assets : 0.37 (As of May. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NextCell Pharma AB's operating assets for the quarter that ended in May. 2024 was kr40.33 Mil. NextCell Pharma AB's operating liabilities for the quarter that ended in May. 2024 was kr14.11 Mil. NextCell Pharma AB's Total Assets for the quarter that ended in Feb. 2024 was kr70.54 Mil. Therefore, NextCell Pharma AB's scaled net operating assets (SNOA) for the quarter that ended in May. 2024 was 0.37.


NextCell Pharma AB Scaled Net Operating Assets Historical Data

The historical data trend for NextCell Pharma AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Scaled Net Operating Assets Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.33 0.16 0.37 0.12 0.21

NextCell Pharma AB Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.27 0.29 0.31 0.37

Competitive Comparison of NextCell Pharma AB's Scaled Net Operating Assets

For the Biotechnology subindustry, NextCell Pharma AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Scaled Net Operating Assets falls into.



NextCell Pharma AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NextCell Pharma AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Aug. 2023 )
=(Operating Assets (A: Aug. 2023 )-Operating Liabilities (A: Aug. 2023 ))/Total Assets (A: Aug. 2022 )
=(38.802-13.1)/124.655
=0.21

where

Operating Assets(A: Aug. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=88.827 - 50.025
=38.802

NextCell Pharma AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in May. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: May. 2024 )
=(Operating Assets (Q: May. 2024 )-Operating Liabilities (Q: May. 2024 ))/Total Assets (Q: Feb. 2024 )
=(40.327-14.107)/70.542
=0.37

where

Operating Assets(Q: May. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=61.124 - 20.797
=40.327

Operating Liabilities(Q: May. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=14.107 - 0 - 0
=14.107

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextCell Pharma AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines